Clinical Trial Update: A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric Participants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating mebendazole for helminth infections in pediatric participants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helminth Infections

Drugs mentioned

• Mebendazole (Mebendazole)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Helminth Infections | Phase 3 | Status: COMPLETED | Results posted: 2016-11-04